- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Syncor shows rebound with 1995 results
Nuclear medicine pharmacy firm Syncor reported solid financialresults for its 1995 fiscal year (end-December), offering furtherproof that the nuclear medicine industry's slump eased last year.The Chatsworth, CA, firm said that both revenues and
Nuclear medicine pharmacy firm Syncor reported solid financialresults for its 1995 fiscal year (end-December), offering furtherproof that the nuclear medicine industry's slump eased last year.The Chatsworth, CA, firm said that both revenues and earningswere up and the company had achieved its financial objectives.
For 1995, Syncor had revenues of $332.5 million, up 4% comparedwith $320 million in 1994. Net income last year stood at $4.7million, up sharply from $1.2 million the year before.
For the fourth quarter, Syncor reported net income of $1.1million on revenues of $85.1 million. In 1994, the company hada loss of $537,000 on sales of $81.7 million.
Syncor said that the improved numbers were due to cost controlprograms, a better product mix, and successful efforts to manageradiopharmaceutical pricing. Cardiology sales continue to driverevenue growth, with sales from cardiology products accountingfor 63% of the company's business in 1995, up from 56% in 1994.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
